Cornerstone Robotics

Cornerstone Robotics is a Hong Kong-based surgical robotics company, founded in 2019 and headquartered at Hong Kong Science Park in Shatin, with additional operations in the Greater Bay Area and the United Kingdom. The company develops the Sentire surgical system, an endoscopic robotic-assisted platform built entirely in-house that combines lightweight surgeon-side arms, tremor filtration, and motion-control techniques intended to help surgeons operate in confined anatomical spaces during minimally invasive procedures. Cornerstone states that Sentire has been used across multiple surgical specialties, including urology, general surgery, gynecology, and thoracic procedures, and the system has been presented at academic venues such as the Hamlyn Symposium on Medical Robotics in July 2026. The company has secured a series of regulatory clearances for Sentire: it received China's National Medical Products Administration approval in September 2024, followed by CE Mark certification under the EU Medical Device Regulation and Singapore's Health Sciences Authority clearance in May 2025, giving the system a multi-market regulatory footprint spanning mainland China, Europe, and Southeast Asia. Cornerstone's stated mission is to make robotic-assisted surgery more accessible and cost-efficient than legacy platforms, targeting hospitals and healthcare systems that have historically been priced out of surgical robotics, and its brand tagline, 'Cornerstone of Better Healthcare,' reflects this affordability-focused positioning. The company has attracted substantial venture financing to support this strategy: it raised over $70 million in an earlier funding round to scale Sentire commercially, followed by a $200 million round reported by MedTech Dive and MassDevice in November 2025 to fund global expansion of the platform. Cornerstone's engineering approach spans mechanical design, electrical engineering, control software, and visual imaging systems developed by an internal R&D team, and the company has described partnerships with hospitals and research institutions to validate clinical use cases as it pursues broader international market entry beyond China and Hong Kong. Public information about Cornerstone's total headcount, manufacturing location for the Sentire hardware, and specific hospital deployment sites is not disclosed on the company's website, and detailed technical specifications of the Sentire arms are limited to what has been described in press coverage and academic presentations rather than a published datasheet.